Excess lipolysis, hepatocellular FFA uptake, and increased (fasting) DNL due to insulin resistance are predominant factors to be considered, when aiming at preventing the disease onset and progression by means of AMPK activation. The gene discussed is PRKAA1; the disease is Insulin resistance.